ARPO | Aerpio Pharmaceuticals Inc 1.61 -0.01 (-0.54%)
Category: Consumer goods
Quick infos Headquarters: Blue Ash, Ohio, United States Trade prices Volume: Market Cap: 74.91M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 13, 2021
Earnings History Date EPS / Forecast Revenue / Forecast May 13, 2021 March 11, 2021 -0.1 / -0.1334- / 2MNovember 10, 2020 -0.12 / -0.14- / -August 12, 2020 0.23 / 0.2715M / 15MMay 7, 2020 -0.1 / -0.0915.00M / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER Mar 12, 2021 1.6200 1.5500 1.6650
1.5400
1.04M 1.25% Mar 11, 2021 1.6000 1.6300 1.6800
1.5800
862.06K 0.63% Mar 10, 2021 1.5900 1.5500 1.6400
1.5500
822.81K 0.63% Mar 9, 2021 1.5800 1.5500 1.6100
1.5500
584.49K 5.33% Mar 8, 2021 1.5000 1.4700 1.5550
1.4413
709.54K 2.04% Mar 5, 2021 1.4700 1.4800 1.5100
1.2500
3.85M -5.16% Mar 4, 2021 1.5500 1.6700 1.6750
1.4900
1.73M -8.82% Mar 3, 2021 1.7000 1.7400 1.7850
1.6000
1.43M -2.3% Mar 2, 2021 1.7400 1.7600 1.8100
1.7200
599.61K -1.14% Mar 1, 2021 1.7600 1.8000 1.8200
1.7400
512.05K -1.12% view more
News
Greater Cincinnati pharma firms stock plummets bizjournals.com Oct 15, 2020 1:41 pm
Has Aerpio Pharmaceuticals (ARPO) Outpaced Other Medical Stocks This Year? finance.yahoo.com Oct 15, 2020 11:30 am
Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma finance.yahoo.com Oct 15, 2020 9:00 am
New Strong Buy Stocks For May 21st finance.yahoo.com Oct 15, 2020 8:01 am
Aerpio Reports First Quarter 2018 Financial Results and Provides Company Update finance.yahoo.com Oct 15, 2020 7:00 am
Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease finance.yahoo.com Oct 15, 2020 7:00 am
Aerpio Pharmaceuticals Announces Review of Strategic Alternatives finance.yahoo.com Oct 15, 2020 5:00 am Aerpio Pharms EPS misses by $0.04, revenue in-line seekingalpha.com Aug 12, 2020 8:04 pm
Aerpio Reports Second Quarter 2020 Financial Results and Provides Business Update finance.yahoo.com Aug 12, 2020 8:00 am Aerpio Pharma up big on funding of razuprotafib study in COVID-19 seekingalpha.com Aug 5, 2020 8:26 pm
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings finance.yahoo.com Aug 5, 2020 7:35 am
Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know finance.yahoo.com Jun 29, 2020 5:50 pm Aerpio launches mid-stage study of razuprotafib in glaucoma seekingalpha.com Jun 24, 2020 9:28 pm
Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial finance.yahoo.com Jun 24, 2020 8:00 am
Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com Jun 12, 2020 11:30 am
New Strong Buy Stocks for April 24th finance.yahoo.com Apr 24, 2020 7:24 am
Immunovant (IMVT) Catches Eye: Stock Jumps 5% finance.yahoo.com Apr 16, 2020 8:39 am
Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know finance.yahoo.com Jun 19, 2020 5:45 pm
New Strong Buy Stocks For June 15th finance.yahoo.com Jun 15, 2020 10:07 am
Company News for May 29, 2020 finance.yahoo.com May 29, 2020 9:59 am Talk about Aerpio Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.